NEW YORK, Oct. 5 /PRNewswire/ -- Pink OTC Markets Inc. (OTCQX: PINK), the financial information and technology services company that operates the leading electronic quotation and trading system in the U.S. OTC securities market, today announced that Competitive Technologies, Inc. (OTCQX: CTTC), a full service technology transfer and licensing provider, is now trading on the OTC market's highest tier, OTCQX®.
(Logo: http://photos.prnewswire.com/prnh/20090708/NY43125LOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20090708/NY43125LOGO)
"Investors prefer the quality-controlled admission process on OTCQX which identifies the segment of OTC-traded companies focused on valuation and transparency," said R. Cromwell Coulson, President and CEO of Pink OTC Markets. "We are pleased to welcome Competitive Technologies to OTCQX."
Competitive Technologies began trading today on the OTC market's prestigious tier, OTCQX U.S. Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcqx.com and www.otcmarkets.com.
"We are delighted to be accepted onto the most prestigious tier of the OTC market," said Johnnie D. Johnson, CEO of Competitive Technologies. "We are committed to providing our stockholders with a superior trading platform and appreciate this validation of our commitment to open and transparent business practices. This platform provides us the ability to show current and potential investors the financial benefits of our revolutionary Calmare® Pain Therapy medical device."
The Cutler Law Group will serve as Competitive Technologies' Designated Advisor for Disclosure ("DAD") on OTCQX, responsible for providing guidance on OTCQX requirements.
About Competitive Technologies, Inc.
Competitive Technologies, Inc. (OTCQX: CTTC) is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTTC is a global leader in identifying, developing, and commercializing innovative technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors.
The non-invasive Calmare® pain therapy device uses the biophysical Scrambler Therapy technology, which was developed in Italy by CTT's client, Professor Giuseppe Marineo. CTTC's partner, GEOMC Co., Ltd of Seoul, Korea is manufacturing the Calmare device, which has U.S. FDA clearance and European Union CE Mark clearance for sales. For more information about Calmare Pain Therapy Treatment, visit www.calmarett.com.
About OTCQX
The OTCQX marketplace is the premier tier of the U.S. OTC market. Investor-focused companies use the quality-controlled OTCQX platform to offer investors transparent trading, superior information, and easy access through their regulated U.S. broker-dealers. The innovative OTCQX platform offers companies and their shareholders a level of marketplace services formerly available only on a U.S. stock exchange. For more information and to view a full list of OTCQX companies, visit www.otcqx.com.
About Pink OTC Markets Inc.
Pink OTC Markets Inc. (OTCQX: PINK) operates the leading electronic interdealer quotation and trading system for over 9,000 securities not listed on a U.S. stock exchange. Pink OTC Markets segments these securities into three tiers: the quality-controlled OTCQX marketplace, the U.S. registered and reporting OTCQB marketplace, and the speculative trading Pink Sheets marketplace. These three tiers constitute the third largest U.S. liquidity pool for trading public company shares, after The NASDAQ Stock Market, Inc. and The New York Stock Exchange. Our products and services promote market transparency, improve price discovery, facilitate regulatory compliance, and increase the quality of issuer disclosure, to the benefit of all OTC market participants. To learn more about how Pink OTC Markets' products and services make OTC markets more transparent, informed, and efficient, please visit our websites at www.otcmarkets.com, www.pinkotc.com and www.otcqx.com or contact us at [email protected].
Subscribe to the OTCQX RSS Feed
SOURCE Pink OTC Markets Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article